Drug discovery and development – Page 11
-
WebinarDeveloping small-molecule degraders using chemoproteomics
Discover how chemoproteomics can inform the development of small molecule degraders
-
BusinessProtein-based Covid-19 vaccines could overshadow rivals
Although slower to develop, protein-based vaccines are well understood with a strong record of safety and effectiveness
-
ResearchDNA-compatible C–H activation method set to benefit drug discovery
Larger and more diverse DNA-encoded libraries on the cards thanks to new tool
-
NewsRush to approve Covid vaccine prompted by politics may end in disaster
Push by governments to pass a vaccine without appropriate evidence could damage fight against virus
-
BusinessRussian Covid-19 vaccine data raises questions
Suspected data manipulation or fabrication casts shadows over safety trial report for hastily-approved Sputnik V
-
OpinionFacing the challenge of vaccine trials
Russia’s Covid-19 gamble is a stark contrast to even accelerated clinical programmes
-
BusinessRussian vaccine launch shocks scientists
Sputnik V to be approved without large human trial data
-
BusinessEncouraging signs from initial Covid-19 vaccine trials
Human trials deliver positive immune responses, while primate challenge studies suggest protection is possible
-
FeatureWhy is cystic fibrosis so hard to treat?
Claire Jarvis talks to the scientists trying to find new drugs to treat the inherited lung condition
-
ResearchTranslating snail venom research from beach to bench and beyond
Meet Mandë Holford, an interdisciplinary scientist following tangents that arise when exploring the molecular-level workings of venom peptides
-
WebinarIlluminating research with the LightOx PhotoReact 365 benchtop photoreactor
Learn about the LightOx PhotoReact – a benchtop photoreactor enabling reproducible irradiation for photochemical and photobiological applications
-
-
OpinionLooking beyond the next wave
We need to apply lessons from Covid-19 to tackle antimicrobial resistance and climate change
-
BusinessWhat are the risks of fast-tracking a Covid-19 vaccine?
Condensing timelines from years to months inevitably involves compromises
-
BusinessScrambling and gambling to scale up Covid-19 medicines
Organisations work towards making billions of doses of products not yet proven to work
-
OpinionDragons of immunology
Anti-inflammatories like dexamethasone are triumphs amid the pitfalls of the immune system
-
NewsExplainer: how is the vaccine pipeline for Covid-19 looking?
The race to develop a vaccine is almost six months old. Who’s in the lead?
-
PodcastDexamethasone
News that this cheap, ubiquitous steroid drug may reduce deaths in Covid-19 cases has been greeted with cautious optimism
-
NewsCovid-19 is forcing pharma to rethink clinical trials
Drug trials have become a casualty of Covid-19, but the pandemic is also prompting change
-
WebinarWL Gore: Optimising production processes with Design of Experiments
Learn how WL Gore use definitive screening designs to analyse multiple factors and optimise production processes